本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

22.13
-0.3400-1.51%
盤後22.00-0.1300-0.59%16:15 EST
成交量:386.72萬
成交額:8,495.85萬
市值:28.29億
市盈率:122.94
高:22.67
開:21.12
低:20.10
收:22.47
52周最高:30.48
52周最低:16.10
股本:1.28億
流通股本:7,811.99萬
量比:2.20
換手率:4.95%
股息:- -
股息率:- -
每股收益(TTM):0.1800
每股收益(LYR):-1.5970
淨資產收益率:14.10%
總資產收益率:5.13%
市淨率:7.05
市盈率(LYR):-13.86

資料載入中...

2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities